e-learning
resources
London 2016
Monday, 05.09.2016
Clinical and molecular studies in asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics
Ioana Agache (Brasov, Romania), Ioana Agache, Daniel S. Strassser, Axel Klenk, Costel Agache, Hervé Farine, Cristina Ciobanu, Peter M.A. Groenen, Cezmi A. Akdis
Source:
International Congress 2016 – Clinical and molecular studies in asthma
Session:
Clinical and molecular studies in asthma
Session type:
Oral Presentation
Number:
1984
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ioana Agache (Brasov, Romania), Ioana Agache, Daniel S. Strassser, Axel Klenk, Costel Agache, Hervé Farine, Cristina Ciobanu, Peter M.A. Groenen, Cezmi A. Akdis. Serum IL-5 and IL-13 consistently serve as the best predictors for the blood eosinophilia phenotype in adult asthmatics. Eur Respir J 2016; 48: Suppl. 60, 1984
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Periostin as a biomarker in patients with asthma: Associations with eosinophilia and Th2 response
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015
Peripheral blood Th9 cells and IL-9 level in asthma patients with early and dual asthmatic response
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
The prognostic value of IFN-gamma and IL-4 cytokines ratio and CD25+ lymphocytes blood content for asthma exacerbation
Source: Annual Congress 2013 –Studies of asthma in man
Year: 2013
Relation between concentration of TNF-apha, IL-6, CRP and airway hyperresponsiveness in elderly asthmatics
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Blood eosinophils relate more closely to reduced lung function than serum ECP or plasma EDN in young asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Systemic cytokine signaling via IL-17 and its relation to clinical characteristics in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: lung function and biomarkers
Year: 2015
T
H
2 specific biomarker profile determines steroid responsiveness in severe asthma
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Proinflammatory cytokines and IP-10 differentiate neutrophilic and eosinophilic asthma subgroups
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
The combination of elevated FeNO and blood eosinophils relate to reduced lung function and increased bronchial responsiveness in young asthmatics
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Effect of tralokinumab on serum periostin and IgE levels in uncontrolled severe asthma
Source: International Congress 2015 – Advances in the future treatment of severe asthma
Year: 2015
Higher burden of asthma symptoms and increased blood eosinophils in ACOS
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Peripheral blood eosinophilia predicts lower airway eosinophilia in asthma and COPD
Source: International Congress 2015 – Systemic and airway biomarkers
Year: 2015
The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
LATE-BREAKING ABSTRACT: Serum IL-13 is a peripheral biomarker for Type 2 asthma
Source: International Congress 2015 – Emerging strategies for airway disease treatments
Year: 2015
Blood eosinophil count is a useful biomarker to identify patients with severe eosinophilic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Serum levels of IL-10, IL-17F, and IL-33 in asthmatic patients of south India
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept